0001140361-18-022841.txt : 20180510
0001140361-18-022841.hdr.sgml : 20180510
20180510175656
ACCESSION NUMBER: 0001140361-18-022841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180508
FILED AS OF DATE: 20180510
DATE AS OF CHANGE: 20180510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LINDAHL RICHARD S
CENTRAL INDEX KEY: 0001196632
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 18824321
MAIL ADDRESS:
STREET 1: NEXTEL
STREET 2: 2001 EDMUND HALLEY DR
CITY: RESTON
STATE: VA
ZIP: 20191
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2018-05-08
0
0001367644
Emergent BioSolutions Inc.
EBS
0001196632
LINDAHL RICHARD S
400 PROFESSIONAL DRIVE, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2018-05-08
4
A
0
4992
0.00
A
4992
D
Common Stock
2018-05-08
4
A
0
1551
0.00
A
6543
D
Common Stock
2018-05-08
4
A
0
4991
0.00
A
11534
D
Employee Stock Option (Right to Buy)
48.33
2018-05-08
4
A
0
19963
48.33
A
2025-05-07
Common Stock
19963
19963
D
Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period.
Vests in three equal installments on May 7, 2019, May 7, 2020 and May 7, 2021.
/s/ S. Scott Lieberman, Attorney-in-fact
2018-05-10